Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs SCYNEXIS, Inc. (SCYX)

Incannex Healthcare Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $32.8M against $28.5M — 1.2× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (0.00% vs −110.7%). Across the 16 metrics below, Incannex Healthcare Inc. leads on 8 and SCYNEXIS, Inc. on 8.

Valuation

Metric IXHL SCYX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 16.88 1.91 2.08
P/B 0.39 0.59 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 1.65 n/m 12.22
EV/Sales (24.08) 0.54 2.87
Earnings yield (75.75%) (62.76%) (15.94%)
Free cash flow yield (48.87%) (33.85%) 0.00%

Profitability

Metric IXHL SCYX Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) 100.00% 53.51%
Operating margin 0.00% (109.90%) 0.00%
Net margin 0.00% (49.74%) (2.45%)
Free cash flow margin 0.00% (64.67%) 0.00%
Return on equity (47.80%) (18.38%) (0.80%)
Return on assets (41.32%) (15.09%) (1.67%)
Return on invested capital 0.00% (110.72%) 0.00%

Growth

Metric IXHL SCYX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 682.47% 5.22%
EPS growth (last fiscal year) 95.91% 61.36% 42.91%
Revenue growth, 5-year CAGR (29.64%) 179.40% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IXHL SCYX Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 48.81 9.65 2.41
Net debt to EBITDA 2.97 2.54 1.01

Dividend

Metric IXHL SCYX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric IXHL SCYX Drug Manufacturers Specialty & Generic median
Market cap 28.47m 32.84m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack